{"date": "2020/03/21", "journal": "medrxiv", "authors": "Marlena M Siwiak, Pawel Szczesny, Marian P Siwiak", "title": "From a single host to global spread. The global mobility based modelling of the COVID-19 pandemic implies higher infection and lower detection rates than current estimates.", "type": "preprint article", "abstract": "Since\u00a0 the\u00a0 outbreak\u00a0 of\u00a0 the\u00a0 COVID-19\u00a0 pandemic,\u00a0 multiple\u00a0 efforts\u00a0 of\u00a0 modelling\u00a0 of\u00a0 the\u00a0 geo-temporal\u00a0 transmissibility\u00a0 of\u00a0 the\u00a0 virus\u00a0have\u00a0been\u00a0undertaken,\u00a0but\u00a0none\u00a0succeeded\u00a0in\u00a0describing\u00a0the\u00a0pandemic\u00a0at\u00a0 the\u00a0 global\u00a0 level.\u00a0 We\u00a0 propose\u00a0 a\u00a0 set\u00a0 of\u00a0 parameters\u00a0 for\u00a0 the\u00a0first\u00a0COVID-19\u00a0Global\u00a0Epidemic\u00a0and\u00a0Mobility\u00a0 Model\u00a0 (GLEaM).\u00a0 The\u00a0 simulation\u00a0 starting\u00a0 with\u00a0 just\u00a0 a\u00a0 single\u00a0 pre-symptomatic,\u00a0 yet\u00a0 infectious,\u00a0 case\u00a0 in\u00a0 Wuhan,\u00a0 China,\u00a0 results\u00a0 in\u00a0 an\u00a0 accurate\u00a0 prediction\u00a0 of\u00a0 the\u00a0 number\u00a0 of\u00a0 diagnosed\u00a0 cases\u00a0 after\u00a0 125\u00a0 days\u00a0 in\u00a0 multiple countries across three continents.\u00a0 We\u00a0 have\u00a0 built\u00a0 a\u00a0 modified\u00a0 SIR\u00a0 metapopulation\u00a0 transmission\u00a0 model\u00a0 and\u00a0 parameterized\u00a0 it\u00a0 analytically,\u00a0 according\u00a0to\u00a0the\u00a0literature\u00a0and\u00a0by\u00a0fitting\u00a0the\u00a0missing\u00a0parameters\u00a0to\u00a0the\u00a0observed\u00a0dynamics\u00a0of\u00a0the\u00a0virus\u00a0 spread.\u00a0 We\u00a0 compared\u00a0 our\u00a0 results\u00a0 with\u00a0 the\u00a0 number\u00a0 of\u00a0 diagnosed\u00a0 cases\u00a0 in\u00a0 sixteen\u00a0 selected\u00a0 countries\u00a0 which\u00a0 provide\u00a0 reliable\u00a0 statistics\u00a0 but\u00a0differ\u00a0substantially\u00a0in\u00a0terms\u00a0of\u00a0strength\u00a0and\u00a0speed\u00a0of\u00a0undertaken\u00a0 precautions. The obtained 95% confidence intervals for the predictions fit well to the empirical data.\u00a0 The\u00a0 parameters\u00a0 that\u00a0 successfully\u00a0 model\u00a0 the\u00a0 pandemic\u00a0 are:\u00a0 the\u00a0 basic\u00a0 reproduction\u00a0 number\u00a0 R0\u200b,\u200b\u00a0~4\u00b74;\u00a0a\u00a0 latent\u00a0 non-infectious\u00a0 period\u00a0 of\u00a0 1\u00b71.\u00a0days\u00a0followed\u00a0by\u00a04\u00b76\u00a0days\u00a0of\u00a0the\u00a0presymptomatic\u00a0infectious\u00a0period;\u00a0 the\u00a0probability\u00a0of\u00a0developing\u00a0severe\u00a0symptoms,\u00a00\u00b701;\u00a0the\u00a0probability\u00a0of\u00a0being\u00a0diagnosed\u00a0when\u00a0presenting\u00a0", "text": "severe\u00a0 symptoms\u00a0 of\u00a0 0\u00b76;\u00a0 the\u00a0 probability\u00a0 of\u00a0 diagnosis\u00a0 for\u00a0 cases\u00a0with\u00a0mild\u00a0symptoms\u00a0or\u00a0asymptomatic,\u00a00\u00b7001.\u00a0Also,\u00a0the\u00a0higher\u00a0the\u00a0testing\u00a0rate\u00a0per\u00a0country,\u00a0the\u00a0lower\u00a0the\u00a0discrepancy\u00a0between\u00a0data\u00a0(diagnosed\u00a0cases) and model.\u00a0\u00a0Parameters\u00a0 that\u00a0 successfully\u00a0 reproduce\u00a0 the\u00a0 observed\u00a0 number\u00a0 of\u00a0 cases\u00a0 indicate\u00a0 that\u00a0 both\u00a0 R0\u200b\u00a0 and\u00a0 the\u00a0prevalence\u00a0 of\u00a0 the\u00a0 virus\u00a0 might\u00a0 be\u00a0underestimated.\u00a0This\u00a0is\u00a0in\u00a0concordance\u00a0with\u00a0the\u00a0newest\u00a0research\u00a0on\u00a0undocumented\u00a0 COVID-19\u00a0 cases.\u00a0 Consequently,\u00a0 the\u00a0 actual\u00a0 mortality\u00a0 rate\u00a0 is\u00a0 putatively\u00a0 lower\u00a0 than\u00a0estimated.\u00a0 Confirmation\u00a0 of\u00a0 the\u00a0 pandemic\u00a0 characteristic\u00a0 by\u00a0 further\u00a0 refinement\u00a0 of\u00a0 the\u00a0 model\u00a0 and\u00a0screening tests is crucial for developing an effective strategy for the global epidemiological crisis.\u00a0No funding was involved in the research. All work was voluntarily donated by researchers.\u00a0A\u00a0novel\u00a0coronavirus\u00a0SARS-CoV-2\u00a0has\u00a0already\u00a0spread\u00a0into\u00a0186\u00a0countries\u00a0and\u00a0territories\u00a0around\u00a0the\u00a0world\u00a0(as\u00a0 of\u00a0 21\u00a0 March\u00a0 2020).\u00a0 With\u00a0 over\u00a0 250\u00a0 thousand\u00a0 confirmed\u00a0 infections\u00a0 and\u00a0 over\u00a0 10\u00a0 thousand\u00a0 deaths,\u00a0 it\u00a0became\u00a0 a\u00a0 global\u00a0 challenge.\u00a0 COVID-19,\u00a0 the\u00a0 disease\u00a0 caused\u00a0 by\u00a0 this\u00a0 coronavirus,\u00a0 was\u00a0 characterised\u00a0 as\u00a0 a\u00a0pandemic by WHO on 11th of March 2020.\u00a0\u00a0While\u00a0a\u00a0number\u00a0of\u00a0different\u00a0measures\u00a0to\u00a0contain\u00a0the\u00a0virus\u00a0have\u00a0been\u00a0implemented\u00a0by\u00a0countries\u00a0all\u00a0over\u00a0the\u00a0 world,\u00a0 their\u00a0 effectiveness\u00a0 remains\u00a0 to\u00a0 be\u00a0 seen.\u00a0 The\u00a0 models\u00a0 used\u00a0 to\u00a0 inform\u00a0 decision-makers\u00a0 are\u00a0COVID-19 pandemic.\u00a0In\u00a0this\u00a0study,\u00a0we\u00a0present\u00a0putatively\u00a0the\u00a0first\u00a0global\u00a0model\u00a0of\u00a0SARS-CoV-2\u00a0spread,\u00a0that\u00a0within\u00a0confidence\u00a0intervals\u00a0 accurately\u00a0depicts\u00a0the\u00a0current\u00a0state\u00a0of\u00a0diagnosed\u00a0cases\u00a0of\u00a0COVID-19\u00a0for\u00a0multiple\u00a0countries\u00a0at\u00a0once. Implications on the transmissibility and policymaking are also discussed.\u00a0Multiple\u00a0 efforts\u00a0 of\u00a0 calculating\u00a0 the\u00a0 transmissibility\u00a0 of\u00a0 the\u00a0 SRAS-Cov-2\u00a0 virus\u00a0 and\u00a0 its\u00a0 geo-temporal\u00a0modelling\u00a0 have\u00a0 been\u00a0 undertaken,\u00a0 but\u00a0 none\u00a0 of\u00a0 the\u00a0 models\u00a0 succeeded\u00a0 to\u00a0 describe\u00a0 the\u00a0 pandemic\u00a0 at\u00a0the\u00a0In\u00a0 fact,\u00a0 many\u00a0 COVID-19\u00a0 cases\u00a0 pass\u00a0 unnoticed\u00a0 (in\u00a0 China,\u00a0 over\u00a0 50%\u00a0 according\u00a0 to\u00a0 the\u00a0 research).\u00a0 This\u00a0hampers successful modelling of the pandemic.\u00a0This\u00a0 study\u00a0 presents\u00a0 the\u00a0 first\u00a0 global\u00a0 modelling\u00a0 of\u00a0 COVID-19\u00a0 pandemic\u00a0 that\u00a0builds\u00a0on\u00a0top\u00a0of\u00a0successful\u00a04\u00b7\u200b\u200b4.\u00a0It\u00a0is\u00a0higher\u00a0than\u00a0the\u00a0value\u00a0proposed\u00a0by\u00a0WHO,\u00a0but\u00a0best-fits\u00a0the\u00a0observed\u00a0number\u00a0of\u00a0diagnosed\u00a0cases\u00a0over\u00a0 125\u00a0 days\u00a0 in\u00a0 multiple\u00a0 countries\u00a0around\u00a0the\u00a0globe.\u00a0Our\u00a0analysis\u00a0also\u00a0provides\u00a0the\u00a0estimation\u00a0of\u00a0the\u00a0global\u00a0 rate\u00a0 of\u00a0 total\u00a0 diagnosed\u00a0 to\u00a0 undiagnosed\u00a0 cases\u00a0 of\u00a0 0\u00b7\u200b\u200b0061.\u00a0 The\u00a0 set\u00a0 of\u00a0 parameters\u00a0 used\u00a0 in\u00a0 our\u00a0simulation form a solid foundation for further modelling of the pandemic.\u00a0Our\u00a0model\u00a0implies\u00a0that\u00a0the\u00a0current\u00a0consensus\u00a0on\u00a0the\u00a0basic\u00a0reproduction\u00a0number\u00a0of\u00a0SARS-CoV-2\u00a0and\u00a0its\u00a0be\u00a0 confirmed\u00a0 on\u00a0 the\u00a0 basis\u00a0 of\u00a0 reliable\u00a0 data,\u00a0 and\u00a0 its\u00a0 prevalence\u00a0 determined\u00a0 by\u00a0 conducting\u00a0 properly\u00a0non-drug interventions and policymaking.\u00a0The\u00a0 model\u00a0 is\u00a0 based\u00a0 on\u00a0 The\u00a0 Global\u00a0 Epidemic\u00a0 and\u00a0 Mobility\u00a0 Model\u00a0 (GLEaM)\u00a0 framework\u200b1,\u200b\u00a0 used\u00a0 through\u00a0GLEAMviz\u00a0 software\u00a0 2\u200b.\u200b\u00a0 GLEaM\u00a0 model\u00a0 integrates\u00a0 sociodemographic\u00a0 and\u00a0 population\u00a0 mobility\u00a0 data\u00a0 in\u00a0 a\u00a0spatially\u00a0 structured\u00a0 stochastic\u00a0 disease\u00a0 approach\u00a0 to\u00a0simulate\u00a0the\u00a0spread\u00a0of\u00a0epidemics\u00a0at\u00a0the\u00a0worldwide\u00a0scale.\u00a0 It\u00a0 was\u00a0 previously\u00a0 used\u00a0for\u00a0real-time\u00a0numerical\u00a0forecast\u00a0of\u00a0global\u00a0spreading\u00a0of\u00a0A/H1N1\u00a0 3\u200b,\u200b\u00a0 and\u00a0 the\u00a0accuracy of this modelling was later confirmed\u200b3.\u200b\u00a0The\u00a0reference\u00a0data\u00a0about\u00a0the\u00a0number\u00a0of\u00a0SARS-CoV-2\u00a0diagnosed\u00a0patients\u00a0in\u00a0the\u00a0period\u00a0from\u00a0Jan\u00a022,\u00a02020,\u00a0Center GitHub repository \u200bhttps://github.com/CSSEGISandData/COVID-19\u200b.\u00a0Information\u00a0about\u00a0the\u00a0severity\u00a0of\u00a0developed\u00a0symptoms\u00a0and\u00a0testing\u00a0rates\u00a0per\u00a0country\u00a0was\u00a0derived\u00a0from\u00a0worldometer.info\u00a0website\u00a0\u200bhttps://www.worldometers.info/coronavirus/\u00a0and\u00a0Other\u00a0 data\u00a0 sources,\u00a0 such\u00a0 as\u00a0 subpopulation\u00a0 selection,\u00a0 commuting\u00a0 patterns,\u00a0 or\u00a0 air\u00a0 travel\u00a0 flows\u00a0 used\u00a0during simulation are embedded in the GLEAM software and well described by its developers.\u00a0Below\u00a0 and\u00a0 in\u00a0 (\u200bTable\u00a0 1)\u200b\u00a0 we\u00a0 present\u00a0 two\u00a0 subsets\u00a0 of\u00a0 model\u00a0 parameters:\u00a0 1)\u00a0 reliable\u00a0 and\u00a0 evidence-based\u00a0derived from literature, and 2) knowledge and analysis-based estimations.\u00a0The average latency period (l\u200bp\u200b)of 5\u00b76 days is a consensus of different estimations calculated previously \u200b4.\u200b\u00a0\u00a0Due\u00a0to\u00a01)\u00a0long\u00a0l\u200bp\u200b,\u00a0effectively\u00a0much\u00a0longer\u00a0than\u00a0reported\u00a0for\u00a0other\u00a0coronaviruses,\u00a0and\u00a02)\u00a0known\u00a0cases\u00a0of\u00a0other\u00a0 viruses\u00a0 7\u200b)\u200b\u00a0 and\u00a0 2)\u00a0 average\u00a0 presymptomatic\u00a0 infectious\u00a0period\u00a0(p\u200bip\u200b)\u00a0of\u00a04\u200b\u00b75\u00a0days.\u00a0This\u00a0split\u00a0produces\u00a0two parameters used in the model:\u00a0\u00a01) latency rate for the non-infectious period - non-infectious epsilon (n\u200bi\u03b5\u200b):\u00a0and\u00a02) latency rate for the infectious period - latency rate infectious epsilon (i\u200b\u03b5\u200b):\u00a0ni\u03b5 = 1/lnip ,\u00a0i\u03b5 = 1/(lp \u2212 lnip) .\u00a0As\u00a0 the\u00a0 Republic\u00a0 of\u00a0 Korea\u00a0 provides\u00a0 high\u00a0 quality,\u00a0 reliable\u00a0 data\u00a0 and\u00a0 conducted\u00a0 a\u00a0 large\u00a0 number\u00a0 of\u00a0 tests\u00a0mild\u00a0 symptoms,\u00a0 in\u00a0 contrast\u00a0 to\u00a0 those\u00a0 in\u00a0 severe\u00a0 condition,\u00a0 are\u00a0 still\u00a0 capable\u00a0 of\u00a0 travelling.\u00a0 For\u00a0 model\u00a0simplicity, we decided to merge into one compartment mild and asymptomatic cases.\u00a0\u00a0We\u00a0 decided\u00a0 to\u00a0 set\u00a0 the\u00a0 probability\u00a0 of\u00a0 detection\u00a0 of\u00a0 severe\u00a0 infection\u00a0 (p\u200bDS\u200b)\u00a0 to\u00a0 0\u200b.6\u200b,\u00a0 in\u00a0order\u00a0to\u00a0accurately\u00a0those\u00a0 caused\u00a0 by\u00a0 their\u00a0 general\u00a0 health\u00a0 condition\u00a0 and\u00a0 not\u00a0 reported\u00a0 on\u00a0 time.\u00a0 Secondly,\u00a0 the\u00a0 model\u00a0 is\u00a0low quality or underfinanced healthcare.\u00a0Another\u00a0 parameter\u00a0 of\u00a0 the\u00a0 model,\u00a0 p\u200bDM\u00a0 is\u00a0 the\u00a0 probability\u00a0 of\u00a0 being\u00a0 diagnosed\u00a0 with\u00a0 COVID-19\u00a0 when\u00a0defined p\u200bS\u200band p\u200bDS\u200b,as well as the rate of total diagnosed to undiagnosed cases (t\u200bDR\u200b):\u00a0pDM = (tDR \u2212 pS * pDS) \u00f7 (1 \u2212 pS) .\u00a0Knowing\u00a0 the\u00a0 limitations\u00a0 of\u00a0 previous\u00a0 modelling\u00a0 attempts\u00a0 9\u200b\u201315\u200b,\u00a0 we\u00a0 decided\u00a0 to\u00a0 test\u00a0 a\u00a0 radically\u00a0 different\u00a0COVID-19\u00a0 epidemiologic\u00a0 paradigm,\u00a0 i.e.\u00a0 to\u00a0 significantly\u00a0 lower\u00a0t\u200bDR\u200b.\u00a0 This\u00a0 means\u00a0 that\u00a0 in\u00a0 our\u00a0 model\u00a0 we\u00a0plus\u00a0 the\u00a0 fact\u00a0 that\u00a0 the\u00a0 potential\u00a0 low\u00a0 detectability\u00a0 has\u00a0 already\u00a0 been\u00a0 discussed\u00a0 in\u00a0 the\u00a0 literature\u200b16,\u200b\u00a0 we\u00a0decided\u00a0 to\u00a0 test\u00a0 such\u00a0a\u00a0possibility\u00a0in\u00a0simulation\u00a0by\u00a0setting\u00a0the\u00a0lowest\u00a0possible\u00a0t\u200bDR\u200b.\u00a0 Its\u00a0 \u200brelation\u00a0to\u00a0p\u200bDM\u00a0limits its minimum to:\u00a0tDR > pS * pDS .\u00a0For\u00a0 previously\u00a0 set\u00a0 p\u200bS\u00a0 and\u00a0 p\u200bDS\u00a0 \u200bvalues,\u00a0 t\u200bDR\u00a0 \u200bmust\u00a0 be\u00a0 greater\u00a0 than\u00a0 0.006,\u00a0 thus\u00a0 the\u00a0 value\u00a0 used\u00a0 in\u00a0 our\u00a0simulation was set to 0.0061.\u00a0\u00a0Another\u00a0 important\u00a0 and\u00a0 deeply\u00a0 interconnected\u00a0 parameters\u00a0 required\u00a0 by\u00a0 the\u00a0 model\u00a0 are\u00a0 as\u00a0 follows:\u00a0 the\u00a0but were not diagnosed, r\u200b\u03b2\u200b;and average recovery time since symptoms development \u03bc\u200b\u200b.\u00a0The\u00a0 parameter\u00a0 \u03b2\u200b\u00a0 is\u00a0 derived\u00a0 from\u00a0 the\u00a0 time\u00a0 a\u00a0 host\u00a0 remains\u00a0 infectious,\u00a0 d\u200b\u200b,\u00a0 and\u00a0 the\u00a0 basic\u00a0 reproduction\u00a0number of the virus, R\u200b0\u200b\u200b:\u00a0where:\u00a0\u03b2 = R0 \u00f7 d ,\u00a0d = \u03bc + pip .\u00a0The\u00a0estimation\u00a0of\u00a0R0\u200b\u00a0is\u00a0a\u00a0topic\u00a0widely\u00a0discussed\u00a0in\u00a0the\u00a0literature,\u00a0with\u00a0values\u00a0ranging\u00a0from\u00a01\u00b74\u00a0to\u00a06\u00b749\u00a01\u200b7\u201322\u00a0.\u00a0 However,\u00a0 following\u00a0 the\u00a0 assumption\u00a0 of\u00a0much\u00a0higher\u00a0than\u00a0the\u00a0currently\u00a0assumed\u00a0rate\u00a0of\u00a0undiagnosed\u00a0the range of 2-5, modelled for SARS \u200b7.\u200b The assumed R0\u200b\u200bvalue leading to presented results is 4\u00b74.\u00a0In\u00a0 our\u00a0 study\u00a0 \u03bc\u200b\u00a0 is\u00a0 derived\u00a0 from\u00a0 a\u00a0 safe\u00a0 quarantine\u00a0 period\u00a0for\u00a0diagnosed\u00a0cases\u00a0 6\u200b.\u200b\u00a0 As\u00a0 the\u00a0 safe\u00a0 quarantine\u00a0in d\u200b\u200be\u200bqual to 1\u200b1\u00b75 days\u200b,and parameter \u03b2\u200b\u200bequal to 0\u200b.38261\u200b.\u00a0\u00a0We\u00a0decided\u00a0to\u00a0set\u00a0r\u200b\u03b2\u00a0to\u00a00.5,\u00a0following\u00a0the\u00a0assumption\u00a0for\u00a0this\u00a0parameter\u00a0used\u00a0in\u00a0GLEaM\u00a0modelling\u00a0of\u00a02009\u00a0 influenza\u00a0 outbreak\u00a0 1\u200b.\u200b\u00a0 Patients\u00a0 who\u00a0 were\u00a0 diagnosed\u00a0 with\u00a0 the\u00a0 SARS-CoV-2\u00a0 infection\u00a0 are\u00a0 assumed\u00a0isolated and as such not spreading the disease any further.\u00a0To\u00a0model\u00a0the\u00a0virus\u00a0spread,\u00a0we\u00a0modified\u00a0the\u00a0compartmental\u00a0SIR\u00a0metapopulation\u00a0transmission\u00a0model\u00a0to\u00a0represent the nature of the COVID-19 epidemic.\u00a0In our model, we use seven different population compartments (\u200bFigure 1)\u200b.\u00a0\u00a0immunity to infection.\u00a0\u00a0symptoms.\u00a0symptoms.\u00a0Susceptible\u00a0 population\u00a0 -\u00a0 equal\u00a0 to\u00a0 the\u00a0 general\u00a0 global\u00a0 population.\u00a0 We\u00a0 assume\u00a0 no\u00a0 existing\u00a02. Latent non-infectious - infected population in the first incubation stage, not yet infectious.\u00a0Presymptomatic\u00a0 infectious\u00a0 -\u00a0 infected\u00a0 population\u00a0 already\u00a0 infectious,\u00a0 but\u00a0 without\u00a0 developed\u00a0Mild\u00a0 symptoms\u00a0 -\u00a0 joint\u00a0 populations\u00a0 of\u00a0 asymptomatic\u00a0 cases\u00a0 and\u00a0 those\u00a0 with\u00a0 inconspicuous\u00a05. Severe symptoms - population of cases with symptoms affecting their travel ability.\u00a06. Diagnosed\u00a0-\u00a0population\u00a0identified\u00a0as\u00a0infected\u00a0with\u00a0SARS-CoV-2\u00a0virus.\u00a0This\u00a0is\u00a0the\u00a0reference\u00a0line\u00a0for the model accuracy.\u00a07. Recovered - joint populations of recovered and fatal cases.\u00a0The\u00a0prepared\u00a0model\u00a0served\u00a0as\u00a0an\u00a0input\u00a0for\u00a010\u00a0runs\u00a0(a\u00a0maximum\u00a0available\u00a0in\u00a0free\u00a0tier)\u00a0of\u00a0GLEaM\u00a0Monte\u00a0Carlo analysis based on human mobility, integrating population and two (local and air) mobility layers.\u00a0The\u00a0simulation\u00a0was\u00a0started\u00a0on\u00a0Nov\u00a012,\u00a02019,\u00a0with\u00a0a\u00a0single\u00a0presymptomatic\u00a0individual\u00a0located\u00a0in\u00a0Wuhan,\u00a0China,\u00a0and\u00a0the\u00a0development\u00a0of\u00a0the\u00a0pandemic\u00a0spread\u00a0was\u00a0modelled\u00a0for\u00a0125\u00a0days.\u00a0The\u00a0model\u00a0does\u00a0not\u00a0have\u00a0any\u00a0 information\u00a0 on\u00a0already\u00a0implemented\u00a0movement\u00a0restrictions\u00a0and\u00a0preventive\u00a0measures\u00a0undertaken\u00a0by\u00a0 different\u00a0 governments.\u00a0 As\u00a0 overall\u00a0 data\u00a0 on\u00a0 the\u00a0 pandemic\u00a0 dynamics\u00a0 around\u00a0the\u00a0globe\u00a0is\u00a0likely\u00a0to\u00a0be\u00a0biased\u00a0 by\u00a0 regions,\u00a0 often\u00a0 considerable\u00a0 in\u00a0 size\u00a0 and\u00a0 population,\u00a0 for\u00a0 which\u00a0 official\u00a0 statistics\u00a0 might\u00a0 be\u00a0inaccurate,\u00a0we\u00a0decided\u00a0not\u00a0to\u00a0compare\u00a0overall\u00a0model\u00a0results\u00a0with\u00a0global\u00a0data,\u00a0but\u00a0to\u00a0limit\u00a0the\u00a0analysis\u00a0of\u00a0modelling\u00a0 results\u00a0 to\u00a0 sixteen\u00a0 countries\u00a0 across\u00a0 four\u00a0 continents\u00a0 (see\u00a0\u200bTable\u00a02)\u200b\u00a0which\u00a0are,\u00a0in\u00a0our\u00a0belief:\u00a0a)\u00a0divergent\u00a0in\u00a0the\u00a0proportion\u00a0of\u00a0the\u00a0tested\u00a0population,\u00a0quality\u00a0of\u00a0healthcare,\u00a0and\u00a0strength\u00a0of\u00a0undertaken\u00a0preventing\u00a0 measures;\u00a0 b)\u00a0 likely\u00a0 to\u00a0 provide\u00a0 the\u00a0public\u00a0with\u00a0real\u00a0data;\u00a0c)\u00a0reporting\u00a0number\u00a0of\u00a0cases\u00a0high\u00a0enough\u00a0to\u00a0assume\u00a0their\u00a0population\u00a0exchange\u00a0with\u00a0the\u00a0rest\u00a0of\u00a0the\u00a0world\u00a0did\u00a0not\u00a0significantly\u00a0change\u00a0the\u00a0pandemic dynamics.\u00a0The\u00a0obtained\u00a095%\u00a0confidence\u00a0intervals\u00a0of\u00a0predicted\u00a0numbers\u00a0of\u00a0diagnosed\u00a0patients\u00a0were\u00a0compared\u00a0with\u00a0empirical\u00a0 data.\u00a0 In\u00a0 F\u200bigure\u00a0 2\u00a0 we\u00a0 present\u00a0 a\u00a0 percentage\u00a0 difference\u00a0 over\u00a0 time\u00a0 between\u00a0 the\u00a0 number\u00a0 of\u00a0reported\u00a0confirmed\u00a0cases\u00a0and\u00a0confidence\u00a0intervals\u00a0limits\u00a0for\u00a0modelled\u00a0predictions.\u00a0Positive\u00a0values\u00a0state\u00a0that\u00a0 the\u00a0 model\u00a0 overestimates\u00a0 the\u00a0 number\u00a0 of\u00a0 diagnosed\u00a0 cases,\u00a0 negative\u00a0 values\u00a0 indicate\u00a0 the\u00a0underestimations\u00a0of\u00a0the\u00a0model.\u00a0Observed\u00a0numbers\u00a0of\u00a0cases\u00a0that\u00a0are\u00a0within\u00a0the\u00a0model\u00a0CIs\u00a0are\u00a0equal\u00a0to\u00a00.\u00a0For selected countries the model predictions fit well to the observed data.\u00a0\u00a0A\u00a0notable\u00a0spread\u00a0of\u00a0the\u00a0model\u00a0accuracy\u00a0between\u00a0the\u00a0countries\u00a0is\u00a0negatively\u00a0proportional\u00a0to\u00a0the\u00a0number\u00a0of\u00a0tests\u00a0performed\u00a0per\u00a0million\u00a0citizens\u00a0reported\u00a0as\u00a0of\u00a0March\u00a09,\u00a02020\u00a0(see\u00a0F\u200bigure\u00a03)\u200b.\u00a0Spearman\u00a0correlation\u00a0coefficient\u00a0 calculated\u00a0 for\u00a0 the\u00a0 number\u00a0 of\u00a0 performed\u00a0 tests\u00a0 and\u00a0 average\u00a0 percentage\u00a0 difference\u00a0 between\u00a0modelled\u00a0 and\u00a0 reported\u00a0 numbers\u00a0 of\u00a0 diagnosed\u00a0cases\u00a0is\u00a0-0\u00b7\u200b\u200b778\u00a0(95%\u00a0confidence\u00a0interval\u00a0 -0\u00b7\u200b\u200b945\u00a0 :\u00a0 -0\u00b7\u200b\u200b291).\u00a0This\u00a0 agrees\u00a0 well\u00a0 with\u00a0 intuition:\u00a0the\u00a0more\u00a0tests\u00a0are\u00a0carried\u00a0in\u00a0the\u00a0country,\u00a0the\u00a0larger\u00a0becomes\u00a0its\u00a0local\u00a0tDR\u200band the model starts underestimating the number of detected cases, and v\u200bice versa\u200b.\u00a0Some\u00a0countries\u00a0present\u00a0epidemic\u00a0dynamics\u00a0different\u00a0from\u00a0the\u00a0model,\u00a0e.g.\u00a0The\u00a0Republic\u00a0of\u00a0Korea,\u00a0Japan,\u00a0or\u00a0 Italy,\u00a0 however,\u00a0 the\u00a0 direction\u00a0 of\u00a0 these\u00a0 deviations\u00a0 may\u00a0 be\u00a0 explained\u00a0by\u00a0the\u00a0measures\u00a0undertaken\u00a0by\u00a0their\u00a0 governments\u00a0 or\u00a0 societal\u00a0 response.\u00a0 We\u00a0 believe\u00a0 that\u00a0 modelling\u00a0 efforts\u00a0 including\u00a0 manual,\u00a0country\u00a0level\u00a0parameter\u00a0modifications\u00a0depending\u00a0on\u00a0specific\u00a0events,\u00a0intervention\u00a0actions,\u00a0and\u00a0society\u00a0response\u00a0to the danger would greatly improve accuracy of the model, but it is outside of the scope of this work.\u00a0The\u00a0 presented\u00a0 model\u00a0 has\u00a0 multiple\u00a0 implications\u00a0 concerning\u00a0 the\u00a0 major\u00a0characteristics\u00a0of\u00a0the\u00a0COVID-19\u00a0pandemic,\u00a0such\u00a0as\u00a0the\u00a0basic\u00a0reproduction\u00a0number\u00a0of\u00a0the\u00a0virus\u00a0R\u200b0\u200b\u00a0 \u00a0(higher\u00a0than\u00a0previously\u00a0assumed,\u00a0yet\u00a0not\u00a0 above\u00a0 the\u00a0 values\u00a0 estimated\u00a0 for\u00a0 other\u00a0 coronaviruses),\u00a0 and\u00a0 the\u00a0 rate\u00a0 of\u00a0diagnosed\u00a0cases\u00a0t\u200bDR\u00a0(\u00a0 \u200bmuch\u00a0lower\u00a0 than\u00a0 assumed\u00a0 so\u00a0 far,\u00a0 especially\u00a0 for\u00a0 cases\u00a0 expressing\u00a0 mild\u00a0 symptoms\u00a0 and\u00a0 asymptomatic).\u00a0 This\u00a0would\u00a0 indicate\u00a0that\u00a0the\u00a0vast\u00a0majority\u00a0of\u00a0the\u00a0COVID-19\u00a0infections\u00a0are\u00a0so\u00a0mild\u00a0that\u00a0they\u00a0pass\u00a0unnoticed.\u00a0This\u00a0is\u00a0not\u00a0implausible,\u00a0considering\u00a0the\u00a0fact\u00a0that\u00a0there\u00a0are\u00a01\u00b7\u200b\u200b9\u00a0billion\u00a0children\u00a0aged\u00a0below\u00a015\u00a0years\u00a0in\u00a0the\u00a0world\u00a0(27%\u00a0of\u00a0the\u00a0global\u00a0population)\u00a0and\u00a0predominantly\u00a0(ca.\u00a090%)\u00a0the\u00a0course\u00a0of\u00a0their\u00a0infections\u00a0is\u00a0mild\u00a0or\u00a0 asymptomatic\u00a0 2\u200b3.\u200b\u00a0 Additionally,\u00a0 they\u00a0 gather\u00a0 in\u00a0 large\u00a0 groups\u00a0 at\u00a0 schools\u00a0 on\u00a0 a\u00a0 regular\u00a0 basis\u00a0 which\u00a0facilitates\u00a0 further\u00a0disease\u00a0transmission.\u00a0Also,\u00a0some\u00a0COVID-19\u00a0cases\u00a0may\u00a0show\u00a0atypical\u00a0symptoms\u00a0 (e.g.\u00a0diarrhoea)\u00a02\u200b4\u00a0which\u00a0hinders\u00a0correct\u00a0diagnosis.\u00a0Taking\u00a0all\u00a0this\u00a0into\u00a0account,\u00a0plus\u00a0the\u00a0results\u00a0of\u00a0our\u00a0model,\u00a0one\u00a0 may\u00a0 risk\u00a0 a\u00a0 hypothesis\u00a0 that\u00a0 the\u00a0 virus\u00a0 is\u00a0 more\u00a0 prevalent\u00a0 in\u00a0 the\u00a0 global\u00a0 population\u00a0 than\u00a0 shown\u00a0 in\u00a0official statistics at the moment, and consequently, its mortality rate is much lower.\u00a0To\u00a0 verify\u00a0 this\u00a0 hypothesis\u00a0 further\u00a0 actions\u00a0 are\u00a0 required.\u00a0 At\u00a0 first,\u00a0the\u00a0model\u00a0should\u00a0be\u00a0simulated\u00a0with\u00a0a\u00a0larger\u00a0 number\u00a0 of\u00a0 iterations,\u00a0 which\u00a0 will\u00a0 narrow\u00a0 obtained\u00a0 confidence\u00a0 intervals\u00a0 and\u00a0 allow\u00a0 further\u00a0refinement\u00a0 of\u00a0 the\u00a0 parameters.\u00a0 Also,\u00a0 a\u00a0 simulation\u00a0 with\u00a0 the\u00a0 t\u200bDR\u00a0 parameter\u00a0 increasing\u00a0 over\u00a0 time\u00a0 or\u00a0geographically\u00a0diverse\u00a0might\u00a0better\u00a0reflect\u00a0the\u00a0actual\u00a0virus\u00a0detectability\u00a0in\u00a0the\u00a0course\u00a0of\u00a0the\u00a0pandemic.\u00a0Finally,\u00a0the\u00a0real\u00a0spread\u00a0of\u00a0the\u00a0virus\u00a0should\u00a0be\u00a0assessed\u00a0empirically\u00a0by\u00a0conducting\u00a0a\u00a0sufficient\u00a0number\u00a0of\u00a0tests\u00a0 on\u00a0 fully\u00a0 random\u00a0 samples\u00a0(currently\u00a0most\u00a0tests\u00a0are\u00a0limited\u00a0to\u00a0individuals\u00a0with\u00a0strong\u00a0and\u00a0typical\u00a0symptoms).\u00a0 Only\u00a0 after\u00a0 obtaining\u00a0a\u00a0solid\u00a0measurement\u00a0of\u00a0the\u00a0actual\u00a0prevalence\u00a0of\u00a0the\u00a0virus,\u00a0one\u00a0might\u00a0draw conclusions about its true mortality rate.\u00a0We\u00a0emphasize\u00a0that\u00a0our\u00a0conclusions\u00a0are\u00a0a\u00a0hypothesis\u00a0based\u00a0on\u00a0a\u00a0single\u00a0computational\u00a0model\u00a0and\u00a0without\u00a0empirical\u00a0 verification,\u00a0 they\u00a0 may\u00a0 serve\u00a0 as\u00a0 a\u00a0 platform\u00a0 for\u00a0 further\u00a0 research.\u00a0 At\u00a0 this\u00a0 stage,\u00a0by\u00a0no\u00a0means\u00a0should\u00a0they\u00a0be\u00a0used\u00a0as\u00a0a\u00a0reason\u00a0for\u00a0governmental\u00a0decisions\u00a0on\u00a0lifting\u00a0the\u00a0precautions.\u00a0Even\u00a0if\u00a0the\u00a0true\u00a0mortality\u00a0 of\u00a0 the\u00a0 virus\u00a0 is\u00a0 indeed\u00a0 lower\u00a0 than\u00a0 announced\u00a0 by\u00a0 the\u00a0 media,\u00a0 many\u00a0 people\u00a0 remain\u00a0 in\u00a0 the\u00a0high-risk\u00a0group.\u00a0Lack\u00a0of\u00a0population\u00a0resistance\u00a0facilitates\u00a0their\u00a0contact\u00a0with\u00a0the\u00a0virus\u00a0and\u00a0may\u00a0lead\u00a0to\u00a0a\u00a0rapid\u00a0 increase\u00a0 of\u00a0 severe\u00a0 cases\u00a0in\u00a0a\u00a0short\u00a0period\u00a0of\u00a0time\u00a0(as\u00a0seen\u00a0in\u00a0Italy)\u00a0leading\u00a0to\u00a0the\u00a0collapse\u00a0of\u00a0the\u00a0healthcare\u00a0system,\u00a0which\u00a0affects\u00a0the\u00a0entire\u00a0society\u00a0and\u00a0results\u00a0in\u00a0many\u00a0additional\u00a0deaths\u00a0not\u00a0related\u00a0to\u00a0the\u00a0 virus\u00a0 itself.\u00a0 Careful\u00a0 use\u00a0 and\u00a0 tuning\u00a0 of\u00a0 non-drug\u00a0 intervention\u00a0 methods,\u00a0 constant\u00a0 balancing\u00a0of\u00a0the\u00a0disease\u00a0 spread\u00a0 and\u00a0 healthcare\u00a0 capacity,\u00a0 protecting\u00a0 the\u00a0 most\u00a0 vulnerable\u00a0 individuals,\u00a0 farsighted\u00a0anticipation\u00a0 and\u00a0 agility\u00a0 in\u00a0 decision\u00a0 making\u00a0 may\u00a0 altogether\u00a0be\u00a0able\u00a0to\u00a0minimize\u00a0the\u00a0number\u00a0of\u00a0deaths\u00a0without resulting in the global economic breakdown.\u00a0MPS, PS, and MMS designed the experiment. PS provided epidemiologic context. MPS and MMS\u00a0collected the data. MPS worked on model parameterization. MMS, MPS and PS wrote the manuscript.\u00a0We declare no competing interests.\u00a0The\u00a0 model\u00a0 and\u00a0 the\u00a0 results\u00a0 of\u00a0 the\u00a0 simulation\u00a0 underlying\u00a0 the\u00a0 presented\u00a0 results\u00a0 is\u00a0 freely\u00a0 available\u00a0 at\u00a0https://github.com/freesci/covid19\u200b.\u00a0123456789101112Balcan D, Gon\u00e7alves B, Hu H, Ramasco JJ, Colizza V, Vespignani A. Modeling the spatial spread of\u00a0infectious diseases: the GLobal Epidemic and Mobility computational model. J\u200bComput Sci\u200b2010; \u200b1:\u200b\u00a0132\u201345.\u00a0Van den Broeck W, Gioannini C, Gon\u00e7alves B, Quaggiotto M, Colizza V, Vespignani A. The GLEaMviz\u00a0computational tool, a publicly available software to explore realistic epidemic spreading scenarios\u00a0at the global scale. B\u200bMC Infect Dis\u200b2011; \u200b11:\u200b37.\u00a0Tizzoni M, Bajardi P, Poletto C, e\u200bt al.\u200bReal-time numerical forecast of global epidemic spreading:\u00a0case study of 2009 A/H1N1pdm. B\u200bMC Med\u200b2012; \u200b10:\u200b165.\u00a0Lauer SA, Grantz KH, Bi Q, e\u200bt al.\u200bThe Incubation Period of Coronavirus Disease 2019 (COVID-19)\u00a0From Publicly Reported Confirmed Cases: Estimation and Application. A\u200bnn Intern Med\u200b2020;\u00a0published online March 10. DOI:1\u200b0.7326/M20-0504\u200b.\u00a0Tong Z-D, Tang A, Li K-F, e\u200bt al.\u200bPotential Presymptomatic Transmission of SARS-CoV-2, Zhejiang\u00a0Province, China, 2020. E\u200bmerg Infect Dis\u200b2020; \u200b26.\u200bDOI:1\u200b0.3201/eid2605.200198.\u200b\u00a0Woelfel R, Corman VM, Guggemos W, e\u200bt al.\u200bClinical presentation and virological assessment of\u00a0hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. m\u200bedRxiv\u00a02020. \u200bhttps://www.medrxiv.org/content/10.1101/2020.03.05.20030502v1.abstract\u200b.\u00a0Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal\u00a0similar impacts of control measures. A\u200bm J Epidemiol\u200b2004; \u200b160:\u200b509\u201316.\u00a0Zhou F, Yu T, Du R, e\u200bt al.\u200bClinical course and risk factors for mortality of adult inpatients with\u00a0COVID-19 in Wuhan, China: a retrospective cohort study. L\u200bancet\u200b2020; published online March 11.\u00a0DOI:1\u200b0.1016/S0140-6736(20)30566-3\u200b.\u00a0Lin Q, Zhao S, Gao D, e\u200bt al.\u200bA conceptual model for the coronavirus disease 2019 (COVID-19)\u00a0outbreak in Wuhan, China with individual reaction and governmental action. I\u200bnt J Infect Dis\u200b2020;\u00a093:\u200b211\u20136.\u00a0Kucharski AJ, Russell TW, Diamond C, e\u200bt al.\u200bEarly dynamics of transmission and control of\u00a0COVID-19: a mathematical modelling study. L\u200bancet Infect Dis\u200b2020; published online March 11.\u00a0DOI:1\u200b0.1016/S1473-3099(20)30144-4\u200b.\u00a0Chen T-M, Rui J, Wang Q-P, Zhao Z-Y, Cui J-A, Yin L. A mathematical model for simulating the\u00a0phase-based transmissibility of a novel coronavirus. I\u200bnfect Dis Poverty\u200b2020; \u200b9:\u200b24.\u00a0Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international\u00a0spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. L\u200bancet\u200b2020;\u00a0395:\u200b689\u201397.\u00a0Cowling BJ, Ali ST, Ng TWY, e\u200bt al.\u200bImpact assessment of non-pharmaceutical interventions against\u00a01415161718192021222324\u00a0COVID-19 and influenza in Hong Kong: an observational study. DOI:1\u200b0.1101/2020.03.12.20034660\u200b.\u00a0Ganyani T, Kremer C, Chen D, e\u200bt al.\u200bEstimating the generation interval for COVID-19 based on\u00a0symptom onset data. m\u200bedRxiv\u200b2020.\u00a0https://www.medrxiv.org/content/10.1101/2020.03.05.20031815v1.abstract\u200b.\u00a0Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel\u00a0coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A\u00a0data-driven analysis. I\u200bnt J Infect Dis\u200b2020; \u200b93:\u200b201\u20134.\u00a0Li R, Pei S, Chen B, e\u200bt al.\u200bSubstantial undocumented infection facilitates the rapid dissemination of\u00a0novel coronavirus (SARS-CoV2). S\u200bcience\u200b2020; published online March 16.\u00a0DOI:1\u200b0.1126/science.abb3221\u200b.\u00a0Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early\u00a0estimation of epidemiological parameters and epidemic predictions. m\u200bedRxiv\u200b2020.\u00a0https://www.medrxiv.org/CONTENT/10.1101/2020.01.23.20018549V2.abstract\u200b.\u00a0Majumder M, Mandl KD. Early Transmissibility Assessment of a Novel Coronavirus in Wuhan,\u00a0China. SSRN Electronic Journal. DOI:1\u200b0.2139/ssrn.3524675\u200b.\u00a0Imai N, Cori A, Dorigatti I, e\u200bt al.\u200bReport 3: transmissibility of 2019-nCoV. R\u200beference Source\u200b2020.\u00a0https://fpmag.net/wp-content/uploads/2020/01/Imperial-2019-nCoV-transmissibility.pdf.\u200b\u00a0Zhao S, Lin Q, Ran J, e\u200bt al.\u200bPreliminary estimation of the basic reproduction number of novel\u00a0coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of\u00a0the outbreak. DOI:1\u200b0.1101/2020.01.23.916395\u200b.\u00a0Statement on the second meeting of the International Health Regulations (2005) Emergency\u00a0Committee regarding the outbreak of novel coronavirus (2019-nCoV).\u00a0https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)\u200b(accessed March 20, 2020).\u00a0Liu Y, Gayle AA, Wilder-Smith A, Rockl\u00f6v J. The reproductive number of COVID-19 is higher\u00a0compared to SARS coronavirus. J\u200bTravel Med\u200b2020; \u200b27.\u200bDOI:1\u200b0.1093/jtm/taaa021\u200b.\u00a0\u00a0\u00a0Country\u00a0Argentina\u00a0Austria\u00a0Bahrain\u00a0Brazil\u00a0Canada\u00a0France\u00a0Germany\u00a0Israel\u00a0Italy\u00a0Japan\u00a0Malaysia\u00a0Mexico\u00a0Spain\u00a0The Republic of Korea\u00a0United Kingdom\u00a0Vietnam\u00a0population.\u00a0Average percentage\u00a0difference\u00a0Tests per million people\u00a0a) presymptomatic, b) who developed mild symptoms, or c) who developed severe symptoms may\u00a0contract the infection at rate \u03b2\u200b\u200b,\u03b2\u200b\u200bor r\u200b\u03b2\u200b*\u03b2\u200b\u200b,respectively, and enters the latent non-infectious\u00a0compartment where he is infected but not yet infectious. During the non-infectious period, each\u00a0individual has a probability of n\u200bi\u200b\u03b5\u200bof becoming \u200bpresymptomatic \u200binfectious. The presymptomatic cases have\u00a0probability i\u200b\u200b\u03b5\u200bo\u200bf developing severe or mild COVID-19 symptomes, with probabilities \u200bpS\u200band (\u200b1-pS)\u200brespectively.\u00a0Transition from symptomatic groups occurs at \u03bc\u200b\u200brate. Individuals who developed severe symptoms do not travel\u00a0within and between modelled subpopulations and may be either diagnosed with probability p\u200bDS\u200b,or to recover with\u00a0probability of 1\u200b-pDS\u200b.Individuals whose mild (or non-existent) symptoms are not stopping them from traveling\u00a0may be diagnosed with probability p\u200bDM\u200bor to recover with probability (\u200b1-pDM)\u200b.\u200bThe diagnosed individuals are\u00a0considered isolated and effectively non-contagious and recover with rate \u03bc\u200b\u200b.The recovery does not discriminate\u00a0between true recovery and fatal cases\u200b.\u00a0\u00a0\u00a0\u00a0confidence intervals limits for modelled predictions. Positive values state that the model overestimates\u00a0the number of diagnosed cases, negative values indicate the underestimations of the model. Observed\u00a0numbers of cases that are within the model CIs are equal to 0.\u00a0people in selected countries of known number of tests (See \u200bTable 2\u200bfor details).\u00a0\u00a0Figure 6\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in Bahrain.\u00a0\u00a0\u00a0Figure 8\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in Canada.\u00a0Figure 9\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in France.\u00a0\u00a0\u00a0\u00a0Figure 12\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in Italy.\u00a0Figure 14\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in the\u00a0Republic of Korea.\u00a0\u00a0Figure 15\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in\u00a0Malaysia.\u00a0Figure 18\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in the UK.\u00a0", "ref_list": [[], ["Coronavirus Disease in China"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "ref_authors": [[], ["Y Dong", "X Mo", "Y Hu", "QY Gao", "YX Chen", "JY Fang"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "fir_para": "severe\u00a0 symptoms\u00a0 of\u00a0 0\u00b76;\u00a0 the\u00a0 probability\u00a0 of\u00a0 diagnosis\u00a0 for\u00a0 cases\u00a0with\u00a0mild\u00a0symptoms\u00a0or\u00a0asymptomatic,\u00a0\n0\u00b7001.\u00a0Also,\u00a0the\u00a0higher\u00a0the\u00a0testing\u00a0rate\u00a0per\u00a0country,\u00a0the\u00a0lower\u00a0the\u00a0discrepancy\u00a0between\u00a0data\u00a0(diagnosed\u00a0\ncases) and model.\u00a0\u00a0", "one_words_summarize": "severe\u00a0 symptoms\u00a0 of\u00a0 0\u00b76;\u00a0 the\u00a0 probability\u00a0 of\u00a0 diagnosis\u00a0 for\u00a0 cases\u00a0with\u00a0mild\u00a0symptoms\u00a0or\u00a0asymptomatic,\u00a00\u00b7001. Also,\u00a0the\u00a0higher\u00a0the\u00a0testing\u00a0rate\u00a0per\u00a0country,\u00a0the\u00a0lower\u00a0the\u00a0discrepancy\u00a0between\u00a0data\u00a0(diagnosed\u00a0cases) and model. Parameters\u00a0 that\u00a0 successfully\u00a0 reproduce\u00a0 the\u00a0 observed\u00a0 number\u00a0 of\u00a0 cases\u00a0 indicate\u00a0 that\u00a0 both\u00a0 R0\u200b\u00a0 and\u00a0 the\u00a0prevalence\u00a0 of\u00a0 the\u00a0 virus\u00a0 might\u00a0 be\u00a0underestimated. Confirmation\u00a0 of\u00a0 the\u00a0 pandemic\u00a0 characteristic\u00a0 by\u00a0 further\u00a0 refinement\u00a0 of\u00a0 the\u00a0 model\u00a0 and\u00a0screening tests is crucial for developing an effective strategy for the global epidemiological crisis. A\u00a0novel\u00a0coronavirus\u00a0SARS-CoV-2\u00a0has\u00a0already\u00a0spread\u00a0into\u00a0186\u00a0countries\u00a0and\u00a0territories\u00a0around\u00a0the\u00a0world\u00a0(as\u00a0 of\u00a0 21\u00a0 March\u00a0 2020). While\u00a0a\u00a0number\u00a0of\u00a0different\u00a0measures\u00a0to\u00a0contain\u00a0the\u00a0virus\u00a0have\u00a0been\u00a0implemented\u00a0by\u00a0countries\u00a0all\u00a0over\u00a0the\u00a0 world,\u00a0 their\u00a0 effectiveness\u00a0 remains\u00a0 to\u00a0 be\u00a0 seen. It\u00a0is\u00a0higher\u00a0than\u00a0the\u00a0value\u00a0proposed\u00a0by\u00a0WHO,\u00a0but\u00a0best-fits\u00a0the\u00a0observed\u00a0number\u00a0of\u00a0diagnosed\u00a0cases\u00a0over\u00a0 125\u00a0 days\u00a0 in\u00a0 multiple\u00a0 countries\u00a0around\u00a0the\u00a0globe. For\u00a0 model\u00a0simplicity, we decided to merge into one compartment mild and asymptomatic cases. Secondly,\u00a0 the\u00a0 model\u00a0 is\u00a0low quality or underfinanced healthcare. Susceptible\u00a0 population\u00a0 -\u00a0 equal\u00a0 to\u00a0 the\u00a0 general\u00a0 global\u00a0 population. The\u00a0obtained\u00a095%\u00a0confidence\u00a0intervals\u00a0of\u00a0predicted\u00a0numbers\u00a0of\u00a0diagnosed\u00a0patients\u00a0were\u00a0compared\u00a0with\u00a0empirical\u00a0 data. In\u00a0 F\u200bigure\u00a0 2\u00a0 we\u00a0 present\u00a0 a\u00a0 percentage\u00a0 difference\u00a0 over\u00a0 time\u00a0 between\u00a0 the\u00a0 number\u00a0 of\u00a0reported\u00a0confirmed\u00a0cases\u00a0and\u00a0confidence\u00a0intervals\u00a0limits\u00a0for\u00a0modelled\u00a0predictions. Observed\u00a0numbers\u00a0of\u00a0cases\u00a0that\u00a0are\u00a0within\u00a0the\u00a0model\u00a0CIs\u00a0are\u00a0equal\u00a0to\u00a00. This\u00a0 agrees\u00a0 well\u00a0 with\u00a0 intuition:\u00a0the\u00a0more\u00a0tests\u00a0are\u00a0carried\u00a0in\u00a0the\u00a0country,\u00a0the\u00a0larger\u00a0becomes\u00a0its\u00a0local\u00a0tDR\u200band the model starts underestimating the number of detected cases, and v\u200bice versa\u200b.\u00a0Some\u00a0countries\u00a0present\u00a0epidemic\u00a0dynamics\u00a0different\u00a0from\u00a0the\u00a0model,\u00a0e.g.\u00a0The\u00a0Republic\u00a0of\u00a0Korea,\u00a0Japan,\u00a0or\u00a0 Italy,\u00a0 however,\u00a0 the\u00a0 direction\u00a0 of\u00a0 these\u00a0 deviations\u00a0 may\u00a0 be\u00a0 explained\u00a0by\u00a0the\u00a0measures\u00a0undertaken\u00a0by\u00a0their\u00a0 governments\u00a0 or\u00a0 societal\u00a0 response. The\u00a0 presented\u00a0 model\u00a0 has\u00a0 multiple\u00a0 implications\u00a0 concerning\u00a0 the\u00a0 major\u00a0characteristics\u00a0of\u00a0the\u00a0COVID-19\u00a0pandemic,\u00a0such\u00a0as\u00a0the\u00a0basic\u00a0reproduction\u00a0number\u00a0of\u00a0the\u00a0virus\u00a0R\u200b0\u200b\u00a0 \u00a0(higher\u00a0than\u00a0previously\u00a0assumed,\u00a0yet\u00a0not\u00a0 above\u00a0 the\u00a0 values\u00a0 estimated\u00a0 for\u00a0 other\u00a0 coronaviruses),\u00a0 and\u00a0 the\u00a0 rate\u00a0 of\u00a0diagnosed\u00a0cases\u00a0t\u200bDR\u00a0(\u00a0 \u200bmuch\u00a0lower\u00a0 than\u00a0 assumed\u00a0 so\u00a0 far,\u00a0 especially\u00a0 for\u00a0 cases\u00a0 expressing\u00a0 mild\u00a0 symptoms\u00a0 and\u00a0 asymptomatic). DOI:1\u200b0.1016/S0140-6736(20)30566-3\u200b.\u00a0Lin Q, Zhao S, Gao D, e\u200bt al.\u200bA conceptual model for the coronavirus disease 2019 (COVID-19)\u00a0outbreak in Wuhan, China with individual reaction and governmental action. Cowling BJ, Ali ST, Ng TWY, e\u200bt al.\u200bImpact assessment of non-pharmaceutical interventions against\u00a01415161718192021222324\u00a0COVID-19 and influenza in Hong Kong: an observational study. Novel coronavirus 2019-nCoV: early\u00a0estimation of epidemiological parameters and epidemic predictions. DOI:1\u200b0.2139/ssrn.3524675\u200b.\u00a0Imai N, Cori A, Dorigatti I, e\u200bt al.\u200bReport 3: transmissibility of 2019-nCoV. R\u200beference Source\u200b2020. The presymptomatic cases have\u00a0probability i\u200b\u200b\u03b5\u200bo\u200bf developing severe or mild COVID-19 symptomes, with probabilities \u200bpS\u200band (\u200b1-pS)\u200brespectively. Figure 12\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in Italy. Figure 15\u200b:An overlay of modelled confidence interval for diagnosed cases and reported values in\u00a0Malaysia."}